Volume 26, Number 7—July 2020
Dispatch
Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand
Table 2
Clinical illness history and calculated intervals of confirmed COVID-19 patients in Bamrasnaradura Infectious Diseases Institute, Bangkok, Thailand, 2020*
Patient no. |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4† | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||||
Onset of symptoms | 0 | 0 | 0 | NA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NA | NA | NA |
Onset of fever | 2 | 0 | 0 | NA | 0 | 0 | 9 | 0 | 1 | 0 | 0 | 0 (0–1.25) | 1.2 (2.8) | – |
First medical visit | 4 | 2 | 4 | 0 | 3 | 4 | 13 | 2 | 3 | 3 | 2 | 3 (2–4) | 3.6 (3.3) | – |
Admitted to BIDI | 4 | 2 | 4 | 0 | 3 | 4 | 13 | 2 | 3 | 8 | 5 | 4 (2–5) | 4.4 (3.5) | – |
SARS-CoV-2 RNA detected | 4 | 2 | 4 | 0 | 3 | 4 | 13 | 2 | 3 | 8 | 5 | 4 (2–5) | 4.4 (3.5) | – |
Fever resolution | 4 | 3 | 6 | NA | 6 | 4 | 13 | 4 | 6 | 13 | 11 | 6 (4–11.5) | 7.0 (3.9) | – |
Clinical resolution | 13 | 10 | 11 | NA | 9 | 9 | 17 | 15 | 9 | 13 | 13 | 12 (9–13.5) | 11.9 (2.8) | – |
SARS-CoV-2 RNA undetectable | 14 | 10 | 13 | 4 | 9 | 26 | 24 | 29 | 9 | 14 | 30 | 14 (9–26) | 16.5 (9.1) | – |
Discharge |
15 |
11 |
14 |
6 |
15 |
29 |
26 |
32 |
11 |
16 |
33 |
15 (11–29) |
18.9 (9.4) |
– |
Calculated intervals | ||||||||||||||
Admission to discharge | 11 | 9 | 10 | 6 | 12 | 25 | 13 | 30 | 8 | 8 | 28 | 11 (8–25) | 14.5 (8.7) | – |
Fever resolution to SARS-COV-2 RNA undetectable | 10 | 7 | 7 | NA | 3 | 22 | 11 | 25 | 3 | 1 | 19 | 9 (3–19.75) | 10.8 (8.4) | – |
Admission to fever resolution | 0 | 1 | 2 | NA | 3 | 0 | 0 | 2 | 3 | 5 | 6 | 2 (0–3.5) | 2.2 (2.1) | – |
Fever resolution to clinical resolution | 9 | 7 | 5 | NA | 3 | 5 | 4 | 11 | 3 | 0 | 2 | 5 (3–7.5) | 4.9 (3.3) | – |
Admission to clinical resolution | 9 | 8 | 7 | NA | 6 | 5 | 4 | 13 | 6 | 5 | 8 | 7 (5–8.25) | 7.1 (2.6) | – |
Fever onset to fever resolution | 2 | 3 | 6 | NA | 6 | 4 | 4 | 4 | 5 | 13 | 11 | 5 (4–7.25) | 5.8 (3.5) | – |
Admission to SARS-COV-2 RNA undetectable | 10 | 8 | 9 | 4 | 6 | 22 | 11 | 27 | 6 | 6 | 25 | 10 (6–22.75) | 12.2 (8.3) | – |
Fever resolution to discharge |
11 |
8 |
8 |
NA |
9 |
25 |
13 |
28 |
5 |
3 |
22 |
10 (7–22.75) |
13.2 (8.7) |
– |
Fever duration by stratified condition | ||||||||||||||
Patients detected through airport screening | 2 | 3 | 6 | – | – | – | – | – | – | – | – | 3 (2–6) | 3.7 (2.1) | 0.14 |
Patients seeking medical care |
– |
– |
– |
– |
6 |
4 |
4 |
4 |
5 |
13 |
11 |
5 (4–11) |
6.7 (3.7) |
– |
Detectable SARS-COV-2 RNA duration by stratified condition | ||||||||||||||
Patients detected through airport screening | 10 | 9 | 8 | – | – | – | – | – | – | – | – | 9 (8–10) | 9.0 (1.0) | 0.17 |
Patients seeking medical care | – | – | – | – | 6 | 22 | 11 | 27 | 6 | 6 | 25 | 11 (6–25) | 14.7 (9.6) | – |
*COVID-19, coronavirus disease; NA, not applicable
†Patient 4 was asymptomatic throughout hospitalization and PCR results reflects days with detectable SARS-CoV-2 RNA following admission.